Spelling suggestions: "subject:"neurotransmitter.""
91 |
Detection approaches for the analysis of volume limited biological samples /Gostkowski, Michael Leonard, January 2000 (has links)
Thesis (Ph. D.)--University of Texas at Austin, 2000. / Vita. Includes bibliographical references. Available also in a digital version from Dissertation Abstracts.
|
92 |
Effects of neurotransmitters and peptides on gastrointestinal motilityin the shark, hemiscyllium plagiosum (Bennett)羅穎祖, Lo, Wing-joe. January 1993 (has links)
published_or_final_version / Zoology / Doctoral / Doctor of Philosophy
|
93 |
SEROTONIN RECEPTOR BINDING: CHARACTERIZATION OF SEROTONIN₁ RECEPTOR SUBTYPESWaters, Stephen Joseph January 1984 (has links)
No description available.
|
94 |
Site of clonidine action to inhibit gut propulsion in mice: Demonstration of a central componentJiang, Qi, 1957- January 1989 (has links)
The role of supraspinal, spinal and peripheral alpha-2 adrenoceptors in the regulation of gastrointestinal motility in mice was investigated using anatomically site specific administration of clonidine and adrenoceptor antagonists. Clonidine produced a dose-dependent inhibition of gastrointestinal transit when given by the i.c.v., i.th., or s.c. routes, and was most potent when given i.c.v. Yohimbine, an alpha-2 adrenoceptor antagonist, but not the alpha-1 antagonist prazosin, antagonized the antitransit effects of clonidine. Yohimbine was most potent in antagonizing i.c.v. clonidine; increased doses of the i.c.v. antagonist were required when the agonist was given s.c. After transection of the spinal cord, i.th. clonidine failed to produce an antitransit effect. Additionally, the i.c.v. potency of clonidine decreased approximately 7-fold in spinally-transected mice. The data suggest that the antitransit effects of clonidine occur through actions at alpha-2 adrenoceptors located at both supraspinal and peripheral sites.
|
95 |
A hardware implementation of the dynamic clampPreyer, Amanda Jervis 08 1900 (has links)
No description available.
|
96 |
Studies on the location and function of some peptidase enzymes in the nervous systemDyer, Simon H. January 1986 (has links)
No description available.
|
97 |
Studies of neurotransmitter release mechanisms in dopamine neurons.Daniel, James, St. Vincent Clinical School, UNSW January 2007 (has links)
Medications that treat diseases such as Parkinson???s disease work by regulating dopamine transmission at synapses. Surprisingly, little is known about the mechanisms regulating dopamine release at synapses. In this thesis, we study mechanisms that regulate vesicle recycling in axons and dendrites of dopamine neurons. Key questions we addressed were: (1) Are vesicles in axons and dendrites associated with the same regulatory proteins, and thus by implication the same regulatory mechanisms, as in excitatory neurons; (2) Do vesicles undergo recycling, and (3) if so, are they characterised by a distinct pool size and rate of recycling. To study this, we cultured dopamine neurons and used immunocytochemistry to detect vesicular monoamine transporter 2 (VMAT2) and identify axons, dendrites and synaptic proteins, combined with labelling of recycling vesicles using FM 1-43. Vesicles in axons, but not in dendrites, were associated with presynaptic proteins such as Synaptophysin and Bassoon. We identified two kinds of presynaptic sites in axons: ???synaptic??? (located close to soma and dendrites??? and ???orphan???. The recycling vesicle pool size was smaller at orphan sites than at synaptic sites, and the initial rate of vesicle pool release was also lower at orphan sites. Both synaptic and orphan sites exhibited lower rates of vesicle pool release compared to hippocampal synapses, suggesting functional differences in presynaptic physiology between dopamine neurons and hippocampal neurons. In somatodendritic regions, VMAT2 was localised to the endoplasmic reticulum, Golgi, endosome, and large dense-core vesicles, suggesting that these vesicles might function as a part of the regulated secretory pathway in mediating dopamine release. None of the synaptic vesicle proteins we studied were detected in these regions, although some preliminary evidence of vesicle turnover was detected using FM 1-43 labelling. This thesis provides a detailed analysis of neurotransmitter release mechanisms in dopamine neurons. Our data suggests that presynaptic release of dopamine is mediated by mechanisms similar to those observed in excitatory neurons. In somatodendritic regions, our data suggests that VMAT2 is localised to organelles in secretory pathways, and that distinct mechanisms of release might be present at somatodendritic sites to those present in presynaptic sites. This thesis provides novel methods for analysing vesicle recycling in dopamine neurons, which provides the basis for further studies examining presynaptic function of dopamine neurons in normal brain function, disease, and therapeutic approaches.
|
98 |
The disposition and fate of histamine in arteries /Stacey, Michael John. January 1984 (has links) (PDF)
Thesis ((Hons) M. Sc.)--University of Adelaide, Dept of Clinical and Experimental Pharmacology, 1984. / Mounted illus. Includes bibliographical references (16 unnumbered leaves at end of vol).
|
99 |
GABA and GABA-receptors in the enteric nervous system /Ong, Jennifer. January 1985 (has links) (PDF)
Thesis (Ph. D.)--University of Adelaide, Dept. of Physiology, 1986. / Includes bibliographical references (leaves 282-354).
|
100 |
Adrenergic mechanisms in rabbit gingival tissues /Parker, Ines. January 1985 (has links) (PDF)
Thesis (M.D.S.)--University of Adelaide, Dept. of Dentistry, 1986. / Includes bibliographical references (leaves 59-68).
|
Page generated in 0.0972 seconds